Synchronized low-dose paclitaxel with timed thoracic radiotherapy (RT) followed by adjuvant chemotherapy (CT) with gemcitabine and carboplatin in stage III non-small cell lung cancer (NSCLC): Results of LJCC 07-01 phase II trial.

J. Zhang; H. Gay; S. M. Russo; T. Parent; P. R. Walker

doi:10.1200/jco.2010.28.15_suppl.e17507

Synchronized low-dose paclitaxel with timed thoracic radiotherapy (RT) followed by adjuvant chemotherapy (CT) with gemcitabine and carboplatin in stage III non-small cell lung cancer (NSCLC): Results of LJCC 07-01 phase II trial.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e17507 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e17507-e17507

Author(s):

J. Zhang ◽

H. Gay ◽

S. M. Russo ◽

T. Parent ◽

P. R. Walker

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Low Dose ◽

Phase Ii Trial ◽

Small Cell ◽

Thoracic Radiotherapy ◽

Small Cell Lung

Download Full-text

PD-084 Phase II trial of gemcitabine-carboplatin-paclitaxel (GCP) as neo-adjuvant chemotherapy for operable non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/s0169-5002(05)80417-9 ◽

2005 ◽

Vol 49 ◽

pp. S91-S92

Author(s):

R. Abratt ◽

J. Lee ◽

J. Han ◽

C. Tsai ◽

M. Boyer ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Neo Adjuvant Chemotherapy

Download Full-text

Pioglitazone and clarithromycin combined with metronomic low-dose chemotherapy versus nivolumab in patients with advanced non-small cell lung cancer treated in 2nd-line and beyond: Outcomes from a randomized phase II trial (ModuLung)

Annals of Oncology ◽

10.1093/annonc/mdz260.092 ◽

2019 ◽

Vol 30 ◽

pp. v646-v647 ◽

Cited By ~ 1

Author(s):

D. Heudobler ◽

C. Schulz ◽

J.R. Fischer ◽

P. Staib ◽

T. Wehler ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Low Dose ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Randomized Phase Ii ◽

Low Dose Chemotherapy

Download Full-text

A phase II trial of adjuvant chemotherapy with weekly paclitaxel (Pac) and carboplatin (Cb) followed by UFT for completely resected pathologic (p-) stage II (N1) and IIIA (N2) non-small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7315 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7315-7315

Author(s):

E. Ogawa ◽

F. Tanaka ◽

K. Yanagihara ◽

H. Wada

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Stage Ii ◽

Weekly Paclitaxel ◽

Small Cell Lung

Download Full-text

Phase II study of low-dose paclitaxel with timed thoracic radiotherapy (TTR) followed by gemcitabine and carboplatin consolidation in patients with unresectable stage III non-small cell lung cancer (NSCLC): NCT 00449657.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.7044 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 7044-7044

Author(s):

J. Zhang ◽

S. M. Russo ◽

H. A. Gay ◽

T. Parent ◽

Z. Nelson ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Low Dose ◽

Phase Ii Study ◽

Small Cell ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

Phase II Trial of Daily Low-dose Carboplatin and Thoracic Radiotherapy in Elderly Patients with Locally Advanced Non-small Cell Lung Cancer

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyd022 ◽

2000 ◽

Vol 30 (2) ◽

pp. 59-64 ◽

Cited By ~ 29

Author(s):

S. Atagi

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Trial ◽

Locally Advanced ◽

Small Cell ◽

Thoracic Radiotherapy ◽

Small Cell Lung

Download Full-text

401P A prospective, phase II trial of low-dose afatinib monotherapy for patients with EGFR, mutation-positive, non-small cell lung cancer (TORG1632)

Annals of Oncology ◽

10.1016/j.annonc.2020.10.395 ◽

2020 ◽

Vol 31 ◽

pp. S1399-S1400

Author(s):

S. Igawa ◽

R. Noro ◽

K. Kubota ◽

K. Naoki ◽

A. Bessho ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Low Dose ◽

Egfr Mutation ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Prospective Phase

Download Full-text

A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L

British Journal of Cancer ◽

10.1038/s41416-018-0243-2 ◽

2018 ◽

Vol 119 (6) ◽

pp. 675-682 ◽

Cited By ~ 11

Author(s):

Tomonari Sasaki ◽

Takashi Seto ◽

Takeharu Yamanaka ◽

Naonobu Kunitake ◽

Junichi Shimizu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Small Cell ◽

Thoracic Radiotherapy ◽

Small Cell Lung

Download Full-text

Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trial

Lung Cancer ◽

10.1016/j.lungcan.2011.01.020 ◽

2011 ◽

Cited By ~ 2

Author(s):

Hamid Sheikh ◽

Rovel Colaco ◽

Paul Lorigan ◽

Fiona Blackhall ◽

Raffaele Califano ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Safety Data ◽

Concurrent Chemotherapy ◽

Small Cell ◽

Thoracic Radiotherapy ◽

Small Cell Lung

Download Full-text

P2-310: Phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel in patients with completely resected non-small cell lung cancer

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000284018.59782.a3 ◽

2007 ◽

Vol 2 (8) ◽

pp. S696

Author(s):

Kenji Sugio ◽

Akira Nagashima ◽

Ryoichi Nakanishi ◽

Hisanobu Sakata ◽

Kozo Nakanishi ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung

Download Full-text

70 Gy thoracic radiotherapy (TRT) is feasible concurrent with chemotherapy for limited stage small cell lung cancer (L-SCLC): preliminary analysis of a CALGB phase II trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(02)03234-0 ◽

2002 ◽

Vol 54 (2) ◽

pp. 103 ◽

Cited By ~ 5

Author(s):

J.A Bogart ◽

J.E Herndon ◽

A.P Lyss ◽

D Watson ◽

A.A Miller ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Preliminary Analysis ◽

Phase Ii Trial ◽

Small Cell ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Limited Stage

Download Full-text